Trust Company of Vermont’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.84M | Buy |
+49,346
| New | +$2.83M | 0.11% | 124 |
|
|
2025
Q4 | $2.97M | Sell |
55,026
-1,450
| -3% | -$69.8K | 0.12% | 119 |
|
|
2025
Q3 | $2.55M | Buy |
56,476
+11,605
| +26% | +$542K | 0.11% | 126 |
|
|
2025
Q2 | $2.08M | Buy |
44,871
+1,023
| +2% | +$50.2K | 0.1% | 137 |
|
|
2025
Q1 | $2.67M | Sell |
43,848
-1,203
| -3% | -$70.1K | 0.13% | 119 |
|
|
2024
Q4 | $2.55M | Buy |
45,051
+5,595
| +14% | +$313K | 0.12% | 122 |
|
|
2024
Q3 | $2.04M | Sell |
39,456
-2,654
| -6% | -$125K | 0.1% | 133 |
|
|
2024
Q2 | $1.75M | Sell |
42,110
-8,803
| -17% | -$394K | 0.1% | 136 |
|
|
2024
Q1 | $2.76M | Buy |
50,913
+1,159
| +2% | +$59K | 0.15% | 116 |
|
|
2023
Q4 | $2.55M | Sell |
49,754
-51,322
| -51% | -$2.69M | 0.17% | 111 |
|
|
2023
Q3 | $5.87M | Sell |
101,076
-9,013
| -8% | -$552K | 0.4% | 69 |
|
|
2023
Q2 | $7.04M | Buy |
110,089
+79
| +0.1% | +$5.3K | 0.46% | 64 |
|
|
2023
Q1 | $7.62M | Buy |
110,010
+2,794
| +3% | +$197K | 0.53% | 58 |
|
|
2022
Q4 | $7.71M | Sell |
107,216
-489
| -0.5% | -$36.9K | 0.57% | 51 |
|
|
2022
Q3 | $7.66M | Buy |
107,705
+3,676
| +4% | +$267K | 0.61% | 47 |
|
|
2022
Q2 | $8.01M | Buy |
104,029
+3,758
| +4% | +$286K | 0.61% | 50 |
|
|
2022
Q1 | $7.32M | Buy |
100,271
+3,824
| +4% | +$257K | 0.5% | 67 |
|
|
2021
Q4 | $6.01M | Sell |
96,447
-285
| -0.3% | -$16.7K | 0.38% | 82 |
|
|
2021
Q3 | $5.72M | Buy |
96,732
+341
| +0.4% | +$22.5K | 0.41% | 81 |
|
|
2021
Q2 | $6.44M | Buy |
96,391
+543
| +0.6% | +$35.4K | 0.45% | 69 |
|
|
2021
Q1 | $6.05M | Buy |
95,848
+13,203
| +16% | +$821K | 0.45% | 69 |
|
|
2020
Q4 | $5.13M | Buy |
82,645
+739
| +0.9% | +$45.4K | 0.41% | 75 |
|
|
2020
Q3 | $4.94M | Sell |
81,906
-2,213
| -3% | -$133K | 0.45% | 67 |
|
|
2020
Q2 | $4.95M | Sell |
84,119
-23,399
| -22% | -$1.4M | 0.49% | 66 |
|
|
2020
Q1 | $5.99M | Sell |
107,518
-2,120
| -2% | -$130K | 0.56% | 59 |
|
|
2019
Q4 | $7.04M | Buy |
109,638
+51,959
| +90% | +$2.98M | 0.53% | 61 |
|
|
2019
Q3 | $2.92M | Buy |
57,679
+1,229
| +2% | +$57.8K | 0.23% | 100 |
|
|
2019
Q2 | $2.56M | Sell |
56,450
-1,641
| -3% | -$76.4K | 0.21% | 101 |
|
|
2019
Q1 | $2.77M | Sell |
58,091
-1,763
| -3% | -$87.8K | 0.24% | 97 |
|
|
2018
Q4 | $3.11M | Sell |
59,854
-2,170
| -3% | -$117K | 0.3% | 87 |
|
|
2018
Q3 | $3.85M | Sell |
62,024
-5,252
| -8% | -$312K | 0.33% | 84 |
|
|
2018
Q2 | $3.72M | Buy |
67,276
+1,256
| +2% | +$67.8K | 0.33% | 82 |
|
|
2018
Q1 | $4.18M | Sell |
66,020
-569
| -0.9% | -$36.6K | 0.39% | 76 |
|
|
2017
Q4 | $4.08M | Buy |
66,589
+1,071
| +2% | +$67K | 0.38% | 77 |
|
|
2017
Q3 | $4.18M | Buy |
65,518
+1,127
| +2% | +$65.8K | 0.42% | 70 |
|
|
2017
Q2 | $3.59M | Buy |
64,391
+111
| +0.2% | +$6.04K | 0.37% | 80 |
|
|
2017
Q1 | $3.5M | Buy |
64,280
+39
| +0.1% | +$2.14K | 0.38% | 77 |
|
|
2016
Q4 | $3.75M | Buy |
64,241
+9,258
| +17% | +$506K | 0.43% | 69 |
|
|
2016
Q3 | $2.96M | Buy |
54,983
+11
| +0% | +$707 | 0.37% | 84 |
|
|
2016
Q2 | $4.04M | Sell |
54,972
-58
| -0.1% | -$4.1K | 0.54% | 65 |
|
|
2016
Q1 | $3.52M | Buy |
55,030
+983
| +2% | +$62K | 0.49% | 69 |
|
|
2015
Q4 | $3.72M | Buy |
54,047
+10,589
| +24% | +$700K | 0.53% | 64 |
|
|
2015
Q3 | $2.57M | Buy |
43,458
+2,369
| +6% | +$150K | 0.4% | 84 |
|
|
2015
Q2 | $2.73M | Buy |
41,089
+628
| +2% | +$41.4K | 0.4% | 82 |
|
|
2015
Q1 | $2.61M | Sell |
40,461
-467
| -1% | -$29.2K | 0.38% | 85 |
|
|
2014
Q4 | $2.42M | Sell |
40,928
-387
| -0.9% | -$21.8K | 0.35% | 87 |
|
|
2014
Q3 | $2.11M | Sell |
41,315
-216
| -0.5% | -$10.8K | 0.32% | 93 |
|
|
2014
Q2 | $2.02M | Buy |
41,531
+2,682
| +7% | +$132K | 0.31% | 95 |
|
|
2014
Q1 | $2.02M | Sell |
38,849
-283
| -0.7% | -$15.1K | 0.33% | 88 |
|
|
2013
Q4 | $2.08M | Sell |
39,132
-951
| -2% | -$48.4K | 0.35% | 87 |
|
|
2013
Q3 | $1.85M | Buy |
40,083
+58
| +0.1% | +$2.55K | 0.34% | 87 |
|
|
2013
Q2 | $1.79M | Buy |
+40,025
| New | +$1.74M | 0.35% | 85 |
|
Other funds holding BMY
Trust Company of Vermont's BMY Position: Q2 2026 in Review
Trust Company of Vermont opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 49,346 shares worth $2.84M. The stake represents 0.11% of the portfolio and ranks #124 among its holdings. This is a return to the name: Trust Company of Vermont previously reported a position in BMY as recently as Q4 2025.
Trust Company of Vermont first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.01M in Q2 2022. 1,603 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Trust Company of Vermont held 49,346 shares of Bristol-Myers Squibb worth $2.84M as of Q2 2026.
- Bristol-Myers Squibb was a new Trust Company of Vermont position in Q2 2026.
- Bristol-Myers Squibb made up 0.11% of Trust Company of Vermont's portfolio in Q2 2026, its #124 holding.
- Trust Company of Vermont first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Trust Company of Vermont's Bristol-Myers Squibb position peaked at $8.01M in Q2 2022.
- 1,603 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Trust Company of Vermont's 13F filing for Q2 2026, filed 7 Aug 2026.